All Stories

  1. Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes
  2. Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy
  3. Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding
  4. Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma
  5. Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems
  6. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?
  7. Prognosis of Early-Stage Hepatocellular Carcinoma
  8. Low air temperature increases the risk of esophageal variceal bleeding
  9. Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System
  10. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program
  11. Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice
  12. External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan
  13. Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection
  14. A Comparison of Clinical Manifestations and Prognoses Between Patients with Hepatocellular Carcinoma and Child–Pugh Scores of 5 or 6
  15. Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study
  16. A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems
  17. Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy
  18. Wandering abdominal pain due to a floating gallbladder
  19. Inverse Association between Hepatitis B Virus Infection and Fatty Liver Disease: A Large-Scale Study in Populations Seeking for Check-Up
  20. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy
  21. Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC
  22. Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system
  23. Milan Criteria, Multi-nodularity, and Microvascular Invasion Predict the Recurrence Patterns of Hepatocellular Carcinoma After Resection
  24. Hepatic resection can provide long-term survival of patients with non–early-stage hepatocellular carcinoma: Extending the Indication for resection?
  25. Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects
  26. Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study
  27. Hepatitis D Virus Isolates with Low Replication and Epithelial-Mesenchymal Transition-Inducing Activity Are Associated with Disease Remission
  28. The Effect of Age on the Long-term Prognosis of Patients With Hepatocellular Carcinoma After Resection Surgery
  29. Younger Hepatocellular Carcinoma Patients Have Better Prognosis After Percutaneous Radiofrequency Ablation Therapy
  30. Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy
  31. Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular Carcinomas
  32. Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy
  33. A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
  34. Selecting an optimal staging system for hepatocellular carcinoma
  35. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis
  36. Pancreatic Duct Disruption With Autosplenectomy
  37. Abdominal Pain After Endoscopic Hemostasis of Gastric Tumor Bleeding
  38. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
  39. Gastrointestinal bleeding because of hookworm infection diagnosed by capsule endoscopy
  40. Predictive Value of Aspartate Aminotransferase to Alanine Aminotransferase Ratio for Hepatic Fibrosis and Clinical Adverse Outcomes in Patients With Primary Biliary Cirrhosis
  41. Hepatogastric Fistula in One Patient With Liver Abscess
  42. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma
  43. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
  44. Clinical Challenges and Images in GI
  45. Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modification
  46. Autoimmune hepatitis combined with multiple viral infections
  47. Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?
  48. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years
  49. Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy
  50. Hepatitis B Surface Antigen Levels and Sequences of Natural Hepatitis B Virus Variants Influence the Assembly and Secretion of Hepatitis D Virus
  51. Positive Selection of Hepatitis Delta Antigen in Chronic Hepatitis D Patients
  52. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients
  53. Genotypes and Viremia of Hepatitis B and D Viruses Are Associated With Outcomes of Chronic Hepatitis D Patients
  54. Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan
  55. Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan